Linezolid Experience Among MDR-TB Patients in Mumbai
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa3486
Abstract: Background: India has 25% of the world’s tuberculosis. Mumbai is home to 12% of India’s cases that are resistant to rifampin and isoniazid (MDR-TB), but they are often resistant to standard treatment. Linezolid (LZD) resistance… read more here.
Keywords: experience among; culture conversion; lzd; mdr patients ... See more keywords